摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4'-Brom-4-methoxy-2'-hydroxy-chalkon | 1226-10-4

中文名称
——
中文别名
——
英文名称
4'-Brom-4-methoxy-2'-hydroxy-chalkon
英文别名
1-(4-Bromo-2-hydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
4'-Brom-4-methoxy-2'-hydroxy-chalkon化学式
CAS
1226-10-4
化学式
C16H13BrO3
mdl
——
分子量
333.181
InChiKey
AEBIZIFMJZEYHR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    136-137 °C
  • 沸点:
    490.5±45.0 °C(Predicted)
  • 密度:
    1.458±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.06
  • 重原子数:
    20.0
  • 可旋转键数:
    4.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    46.53
  • 氢给体数:
    1.0
  • 氢受体数:
    3.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4'-Brom-4-methoxy-2'-hydroxy-chalkon双氧水 作用下, 以 甲醇 为溶剂, 反应 1.0h, 生成 7-Brom-4'-methoxy-flavonol
    参考文献:
    名称:
    Exploring 3-hydroxyflavone scaffolds as mushroom tyrosinase inhibitors: synthesis, X-ray crystallography, antimicrobial, fluorescence behaviour, structure-activity relationship and molecular modelling studies
    摘要:
    To explore new scaffolds as tyrosinase enzyme inhibitors remain an interesting goal in the drug discovery and development. In due course and our approach to synthesize bioactive compounds, a series of varyingly substituted 3-hydroxyflavone derivatives (1-23) were synthesized in one-pot reaction and screened forin vitroagainst mushroom tyrosinase enzyme. The structures of newly synthesized compounds were unambiguously corroborated by usual spectroscopic techniques (FTIR, UV-Vis,H-1-,C-13-NMR) and mass spectrometry (EI-MS). The structure of compound15was also characterized by X-ray diffraction analysis. Furthermore, the synthesized compounds (1-23) were evaluated for their antimicrobial potential. Biological studies exhibit pretty good activity against most of the bacterial-fungal strains and their activity is comparable to those of commercially available antibioticsi.e.Cefixime and Clotrimazole. Amongst the series, the compounds2, 4, 5, 6, 7, 10, 11, 14and22exhibited excellent inhibitory activity against tyrosinase, even better than standard compound. Remarkably, the compound2(IC50= 0.280 +/- 0.010 mu g/ml) was found almost sixfold and derivative5(IC50= 0.230 +/- 0.020 mu g/ml) about sevenfold more active as compared to standard Kojic acid (IC50=1.79 +/- 0.6 mu g/ml). Moreover, these synthetic compounds (1-23) displayed good to moderate activities against tested bacterial and fungal strains. Their emission behavior was also investigated in order to know their potential as fluorescent probes. The molecular modelling simulations were also performed to explore their binding interactions with active sites of the tyrosinase enzyme. Limited structure-activity relationship was established to design and develop new tyrosinase inhibitors by employing 2-arylchromone as a structural core in the future. Communicated by Ramaswamy H. Sarma
    DOI:
    10.1080/07391102.2020.1805364
  • 作为产物:
    描述:
    4-溴-2-羟基苯乙酮4-甲氧基苯甲醛 在 sodium hydroxide 作用下, 以 甲醇 为溶剂, 反应 4.5h, 生成 4'-Brom-4-methoxy-2'-hydroxy-chalkon
    参考文献:
    名称:
    Exploring 3-hydroxyflavone scaffolds as mushroom tyrosinase inhibitors: synthesis, X-ray crystallography, antimicrobial, fluorescence behaviour, structure-activity relationship and molecular modelling studies
    摘要:
    To explore new scaffolds as tyrosinase enzyme inhibitors remain an interesting goal in the drug discovery and development. In due course and our approach to synthesize bioactive compounds, a series of varyingly substituted 3-hydroxyflavone derivatives (1-23) were synthesized in one-pot reaction and screened forin vitroagainst mushroom tyrosinase enzyme. The structures of newly synthesized compounds were unambiguously corroborated by usual spectroscopic techniques (FTIR, UV-Vis,H-1-,C-13-NMR) and mass spectrometry (EI-MS). The structure of compound15was also characterized by X-ray diffraction analysis. Furthermore, the synthesized compounds (1-23) were evaluated for their antimicrobial potential. Biological studies exhibit pretty good activity against most of the bacterial-fungal strains and their activity is comparable to those of commercially available antibioticsi.e.Cefixime and Clotrimazole. Amongst the series, the compounds2, 4, 5, 6, 7, 10, 11, 14and22exhibited excellent inhibitory activity against tyrosinase, even better than standard compound. Remarkably, the compound2(IC50= 0.280 +/- 0.010 mu g/ml) was found almost sixfold and derivative5(IC50= 0.230 +/- 0.020 mu g/ml) about sevenfold more active as compared to standard Kojic acid (IC50=1.79 +/- 0.6 mu g/ml). Moreover, these synthetic compounds (1-23) displayed good to moderate activities against tested bacterial and fungal strains. Their emission behavior was also investigated in order to know their potential as fluorescent probes. The molecular modelling simulations were also performed to explore their binding interactions with active sites of the tyrosinase enzyme. Limited structure-activity relationship was established to design and develop new tyrosinase inhibitors by employing 2-arylchromone as a structural core in the future. Communicated by Ramaswamy H. Sarma
    DOI:
    10.1080/07391102.2020.1805364
点击查看最新优质反应信息

文献信息

  • Discovery of 3-bromoflavone derivative D5 as a novel TLR4-MD2 antagonist for treatment of acute lung injury and sepsis
    作者:Xu Cheng、Yijie Wang、Hao Wang、Jing Xu、Lin Wang、Shouguo Zhang、Shuchen Liu、Tao Peng
    DOI:10.1016/j.molstruc.2024.139375
    日期:2024.12
    Toll-like receptor 4 (TLR4) generates severe inflammatory syndromes such as acute lung injury (ALI) and sepsis, thus targeting TLR4 is attractive as a potential pharmacological therapy for these diseases. The aim of this study is to develop a novel structural TLR4 inhibitor for the treatment of ALI and sepsis. Herein, we designed and synthesized a new series of 3-bromoflavone derivatives by screening
    Toll 样受体 4 (TLR4) 介导的免疫反应的异常激活会产生严重的炎症综合征,例如急性肺损伤 (ALI) 和脓毒症,因此针对 TLR4 作为这些疾病的潜在药物治疗方法具有吸引力。本研究的目的是开发一种新型结构 TLR4 抑制剂,用于治疗 ALI 和脓毒症。在此,我们通过筛选和分子对接设计并合成了一系列新的3-溴黄酮生物。通过 ELISA 在巨噬细胞中评估了它们的抗炎作用,并且化合物被确定为最有潜力的抗炎候选物。化合物可抑制脂多糖 (LPS) 诱导的 RAW264.7 细胞中白介素 6 (IL-6) 和肿瘤坏死因子 -α (TNF-α) 的表达,IC 值分别为 0.215 和 4.211 µM。免疫沉淀、SPR 和免疫印迹表明,靶向 TLR4-MD2 复合物并竞争性抑制 LPS 与 TLR4-MD2 的结合,从而抑制 NF-κB 和 MAPK 信号通路。体内给药显着改善LPS诱导的A
  • 30. Synthesis of 7-halogenoflavone and related compounds
    作者:F. C. Chen、C. T. Chang
    DOI:10.1039/jr9580000146
    日期:——
  • Tuning of environment-sensitive 3-hydroxychromone fluorophores based on strong donor substituents in positions 2 or 7
    作者:Luciana Giordano、Volodymyr V. Shvadchak、Nicolás Arrupe、Lisandro J. Falomir Lockhart、Verónica M. Sánchez、Thomas M. Jovin
    DOI:10.1016/j.dyepig.2023.111479
    日期:2023.10
查看更多

同类化合物

(2Z)-1,3-二苯基-2-丙烯-1-酮,2-丙烯-1-酮,1,3-二苯基-,(2Z)- 龙血素D 龙血素A 龙血素 B 黄色当归醇F 黄色当归醇B 黄腐醇; 黄腐酚 黄腐醇 D; 黄腐酚 D 黄腐酚B 黄腐酚 黄腐酚 黄卡瓦胡椒素 C 高紫柳查尔酮 阿普非农 阿司巴汀 阿伏苯宗 金鸡菊查耳酮 邻肉桂酰苯甲酸 达泊西汀杂质25 豆蔻明 补骨脂色烯查耳酮 补骨脂查耳酮 补骨脂呋喃查耳酮 补骨脂乙素 蜡菊亭; 4,2',4'-三羟基-6'-甲氧基查耳酮 苯酚,4-[3-(2-羟基苯基)-1-苯基丙基]-2-(3-苯基丙基)- 苯磺酰胺,N-[4-[3-(3-羟基苯基)-1-羰基-2-丙烯基]苯基]- 苯磺酰胺,N-[3-[3-(4-羟基-3-甲氧苯基)-1-羰基-2-丙烯基]苯基]- 苯磺酰胺,4-甲氧基-N,N-二甲基-2-(3-羰基-3-苯基-1-丙烯基)-,(E)- 苯磺酰氯化,4,5-二甲氧基-2-(3-羰基-3-苯基-1-丙烯基)-,(E)- 苯磺酰氯,4-甲氧基-3-(3-羰基-3-苯基-1-丙烯基)-,(E)- 苯甲醇,4-甲氧基-a-[2-(4-甲氧苯基)乙烯基]- 苯甲酸-[4-(3-氧代-3-苯基-丙烯基)-苯胺] 苯甲酸,3-[3-(4-溴苯基)-1-羰基-2-丙烯基]-4-羟基- 苯甲酰(2-羟基苯酰)甲烷 苯甲腈,4-(1-羟基-3-羰基-3-苯基丙基)- 苯基[2-(1-萘基)乙烯基]甲酮 苯基-(三苯基-丙-2-炔基)-醚 苯基-(2-苯基-2,3-二氢-苯并噻唑-2-基)-甲酮 苯亚甲基苯乙酮 苯乙酰腈,a-(1-氨基-2-苯基亚乙基)- 苯丙酸,a-苯甲酰-b-羰基-,苯基(苯基亚甲基)酰肼 苯,1-(2,2-二甲基-3-苯基丙基)-2-甲基- 苏木查耳酮 苄桂哌酯 苄基(4-氯-2-(3-氧代-1,3-二苯基丙基)苯基)氨基甲酸酯 芦荟提取物 腈苯唑 胀果甘草宁C 聚磷酸根皮酚